Form 483

CSL Behring GmbH Form 483, 2026-02-18

FDA issued a Form 483 to CSL Behring GmbH on 2026-02-18 with 5 public-safe observations.

483· Form 483 issuedBiologics5 observations

CSL Behring GmbH · Marburg, Germany · Issued February 18, 2026

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Feb 2026
21 CFR 211.100(a)

Changes to Procedures Not Reviewed, Approved

Cited by Travis S Bradley, Burnell M Henry

18 Feb 2026
21 CFR 211.198(a)

Procedures to be written and followed

Cited by Travis S Bradley, Burnell M Henry

18 Feb 2026
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Travis S Bradley, Burnell M Henry

18 Feb 2026
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Travis S Bradley, Burnell M Henry

18 Feb 2026
21 CFR 600.14(a)(1)

Who must report - manufacturer

Cited by Travis S Bradley, Burnell M Henry

Inspected site

CBCSL Behring GmbHMarburg, Germany

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 600.14(a)(1)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere